Adagene milestone in collaboration with Exelixis on SAFEbody ADC candidates
Adagene says it achieved a milestone in its collaboration with Exelixis to advance SAFEbody antibody-drug conjugate candidates.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.